These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ruscogenin inhibits lipopolysaccharide-induced acute lung injury in mice: involvement of tissue factor, inducible NO synthase and nuclear factor (NF)-κB. Sun Q; Chen L; Gao M; Jiang W; Shao F; Li J; Wang J; Kou J; Yu B Int Immunopharmacol; 2012 Jan; 12(1):88-93. PubMed ID: 22079591 [TBL] [Abstract][Full Text] [Related]
3. Total flavonoids of Mosla scabra leaves attenuates lipopolysaccharide-induced acute lung injury via down-regulation of inflammatory signaling in mice. Chen J; Wang JB; Yu CH; Chen LQ; Xu P; Yu WY J Ethnopharmacol; 2013 Jul; 148(3):835-41. PubMed ID: 23747643 [TBL] [Abstract][Full Text] [Related]
4. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-κB pathway. Liu Y; Wu H; Nie YC; Chen JL; Su WW; Li PB Int Immunopharmacol; 2011 Oct; 11(10):1606-12. PubMed ID: 21640201 [TBL] [Abstract][Full Text] [Related]
5. Sclareol ameliorate lipopolysaccharide-induced acute lung injury through inhibition of MAPK and induction of HO-1 signaling. Hsieh YH; Deng JS; Pan HP; Liao JC; Huang SS; Huang GJ Int Immunopharmacol; 2017 Mar; 44():16-25. PubMed ID: 28068646 [TBL] [Abstract][Full Text] [Related]
6. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice. Zhong WT; Wu YC; Xie XX; Zhou X; Wei MM; Soromou LW; Ci XX; Wang DC Fitoterapia; 2013 Oct; 90():132-9. PubMed ID: 23751215 [TBL] [Abstract][Full Text] [Related]
7. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro. Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871 [TBL] [Abstract][Full Text] [Related]
8. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice. San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765 [TBL] [Abstract][Full Text] [Related]
9. 23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways. Chen C; Li L; Liu X; Zhang D; Liu Y; Li Y J Ethnopharmacol; 2023 Jan; 300():115725. PubMed ID: 36115602 [TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling. Liu J; Huang X; Hu S; He H; Meng Z Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263 [TBL] [Abstract][Full Text] [Related]
11. Ugonin M, a Helminthostachys zeylanica Constituent, Prevents LPS-Induced Acute Lung Injury through TLR4-Mediated MAPK and NF-κB Signaling Pathways. Wu KC; Huang SS; Kuo YH; Ho YL; Yang CS; Chang YS; Huang GJ Molecules; 2017 Apr; 22(4):. PubMed ID: 28368327 [No Abstract] [Full Text] [Related]
12. MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway. Fu L; Zhu P; Qi S; Li C; Zhao K Biomed Pharmacother; 2018 Nov; 107():703-711. PubMed ID: 30138892 [TBL] [Abstract][Full Text] [Related]
13. Sangxingtang inhibits the inflammation of LPS-induced acute lung injury in mice by down-regulating the MAPK/NF-κB pathway. Zhang TZ; Yang SH; Yao JF; Du J; Yan TH Chin J Nat Med; 2015 Dec; 13(12):889-95. PubMed ID: 26721707 [TBL] [Abstract][Full Text] [Related]
14. Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice. Xie X; Sun S; Zhong W; Soromou LW; Zhou X; Wei M; Ren Y; Ding Y Int Immunopharmacol; 2014 Mar; 19(1):103-9. PubMed ID: 24412620 [TBL] [Abstract][Full Text] [Related]
15. Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice. Chen X; Yang X; Liu T; Guan M; Feng X; Dong W; Chu X; Liu J; Tian X; Ci X; Li H; Wei J; Deng Y; Deng X; Chi G; Sun Z Int Immunopharmacol; 2012 Oct; 14(2):209-16. PubMed ID: 22835426 [TBL] [Abstract][Full Text] [Related]
16. Protective effects of pogostone against LPS-induced acute lung injury in mice via regulation of Keap1-Nrf2/NF-κB signaling pathways. Sun CY; Xu LQ; Zhang ZB; Chen CH; Huang YZ; Su ZQ; Guo HZ; Chen XY; Zhang X; Liu YH; Chen JN; Lai XP; Li YC; Su ZR Int Immunopharmacol; 2016 Mar; 32():55-61. PubMed ID: 26800098 [TBL] [Abstract][Full Text] [Related]
18. Isorhamnetin protects mice from lipopolysaccharide-induced acute lung injury via the inhibition of inflammatory responses. Chi G; Zhong W; Liu Y; Lu G; Lü H; Wang D; Sun F Inflamm Res; 2016 Jan; 65(1):33-41. PubMed ID: 26525359 [TBL] [Abstract][Full Text] [Related]
19. Isotetrandrine protects against lipopolysaccharide-induced acute lung injury by suppression of mitogen-activated protein kinase and nuclear factor-kappa B. Liang XM; Guo GF; Huang XH; Duan WL; Zeng ZL J Surg Res; 2014 Apr; 187(2):596-604. PubMed ID: 24331940 [TBL] [Abstract][Full Text] [Related]
20. Methanol extract of Antrodia camphorata protects against lipopolysaccharide-induced acute lung injury by suppressing NF-κB and MAPK pathways in mice. Huang GJ; Deng JS; Chen CC; Huang CJ; Sung PJ; Huang SS; Kuo YH J Agric Food Chem; 2014 Jun; 62(23):5321-9. PubMed ID: 24849405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]